Asthma and nasal polyps study to match immune patterns
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study looks at different “immune inflammation patterns” in people with asthma and/or nasal polyps. It may help researchers better tailor future treatments by figuring out which patterns go with which symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 99
- You have a diagnosed asthma condition (or, if you don’t, you must have nasal polyps)
- Your asthma treatment has been stable for at least 12 weeks and is at a certain moderate-to-strong step 4–5 level
- You are not currently using oral steroid pills or asthma/polyps monoclonal antibody medicines
- Recent test results must fit a specific inflammation pattern (blood eosinophils/FeNO or IgE), and you may also need confirmation of nasal polyps by scan or endoscopy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a more thorough sinus surgery combined with removing lymphoid tissue in the throat to see if it helps people with nasal polyps. Researchers want to know if this approach reduces inflammation and improves symptoms.
This trial tests if seeing a lung specialist and an ear-nose-throat doctor together in one visit helps people with asthma and chronic sinusitis (with nasal polyps) feel better than seeing each specialist separately. You may qualify if your asthma or sinusitis is not well-controlled and you've used steroid pills in the past year.
This study looks at how “biologic” medicines work in real-life care for people with severe chronic rhinosinusitis with nasal polyps (CRSwNP). It may help confirm which patients benefit and how treatment is used in everyday practice.
This study looks at why some people with severe chronic nasal polyps respond better to mepolizumab. It may help doctors predict who will benefit from the medicine, and who may need a different plan.
This trial compares three different biologic medications (injectable drugs) to see which one works best for people with chronic sinusitis and nasal polyps. If you have moderate to severe symptoms and are considering biologic therapy, this study might help find the best option for you.
This study looks at blood and other measures (biomarkers) to understand how well mepolizumab helps people with nasal polyps, with or without asthma. It aims to find response clues that could help personalize treatment in the future.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.